Scroll To Top

gilead sciences

happy queer transgender cisgender people lenacapavir HIV prevention drug success
Prevention

Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%

Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.

Eureka O'Hara in 'Canada's Drag Race: Canada vs. the World'
Mental Health

Eureka is taking a break from competing on 'Drag Race' following 'CVTW' elimination

After four appearances in various Drag Race franchises, CVTW's "Miss Congeniality" has no plans of returning to the mainstage any time soon.

Friends at a cafe
Treatment

The FDA Says This Group Can Now Use Biktarvy Safely

The once-daily regimen for those with HIV can now be prescribed to those with a common treatment resistance.

PrEP
Prevention

Blockbuster PrEP Lawsuit: Gilead Wins Over U.S. Government

A jury favored the drugmaker against the CDC’s claims it's owed money for the preventative HIV medication.